S. 2099

Summary

S. 2099, the Restore Prescription Drugs Discount Act, was introduced in the Senate on Jun 17, 2025 by Sen. Rand Paul (R). It was referred to Judiciary, and last saw action on Jun 17, 2025: Read twice and referred to the Committee on the Judiciary.

Record

Text

S. 2099 has no co-sponsors and has not gone to a roll call.

119 S2099 IS: Restore Prescription Drugs Discount Act
 U.S. Senate
 2025-06-17
 text/xml
 EN
 Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
 II  119th CONGRESS  1st Session  S. 2099  IN THE SENATE OF THE UNITED STATES   June 17, 2025   Mr. Paul  introduced the following bill; which was read twice and referred to the  Committee on the Judiciary    A BILL
To repeal the Robinson-Patman Act of 1936.
1.
Short title
This Act may be cited as the   Restore Prescription Drugs Discount Act  .
2.
Repeal
The Act of June 19, 1936 (commonly known as the  Robinson–Patman Act ; 49 Stat. 1526, chapter 592;  15 U.S.C. 13a et seq. ), and the amendments made by that Act, are repealed.

Tracker

The tracker indicates the progress of this legislation as it moves through the legislative process.

A bill to repeal the Robinson-Patman Act of 1936.

Sponsors

Sen. Rand Paul (R) sponsors S. 2099 alone.

Rand Paul

Sen. · R–KY · Sponsor

Show 1 of 1 row

PreviousNext

Committees

S. 2099 went before 1 committee: Judiciary.

Judiciary

Judiciary

Referred To · Jun 17, 2025

Actions

S. 2099 has taken 2 actions since Jun 17, 2025.

Votes

S. 2099 has not gone to a roll call.

Titles

S. 2099 goes by 3 titles, 1 of them short titles.

• Restore Prescription Drugs Discount Act — Short Title(s) as Introduced
• Restore Prescription Drugs Discount Act — Display Title
• A bill to repeal the Robinson-Patman Act of 1936. — Official Title as Introduced

Lobbying

2 clients hired 2 firms and 13 registered lobbyists who named S. 2099 in 6 quarterly filings, 2025 to 2026. Reported under the Lobbying Disclosure Act; a filing’s income covers everything its registrant worked that quarter, so the amounts below are the filings’, not this bill’s.

Filed under Medicare/Medicaid, Pharmacy, Advertising, Consumer Issues/Safety/Products, Insurance, Labor Issues/Antitrust/Workplace, Taxation/Internal Revenue Code, Health Issues.

Clients

Who paid to be heard, by how many filings named the bill.

Firms

Registrants who filed on the bill, by filings.

Lobbyists

Named on the filings that cite the bill.

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, largest reported first.

Classification

The Congressional Research Service files S. 2099 under Health, one of its 31 policy areas.

CRS Subjects

CRS assigns every bill one policy area from its 31; S. 2099’s is Health.

Source: congress.gov · legiscan.com